Company news

NeuroOne Medical Technologies Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

June 3, 2025

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

May 29, 2025

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

May 13, 2025

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

May 12, 2025

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

May 5, 2025

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8: 30 a.m. Eastern Time

May 1, 2025

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

April 23, 2025

NeuroOne® Issues Letter to Shareholders

April 16, 2025

NeuroOne® OneRF® Technology Success Story Featured on Fox News

April 14, 2025

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

April 4, 2025

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

April 3, 2025

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

March 18, 2025

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

March 18, 2025

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy

March 18, 2025

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

March 11, 2025

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

March 5, 2025

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

February 11, 2025

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8: 30 a.m. Eastern Time

February 4, 2025

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

February 3, 2025

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

January 9, 2025

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

January 5, 2025

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11: 00 a.m. EST

January 2, 2025

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

December 16, 2024

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9: 00 a.m. Eastern Time

December 3, 2024

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

November 12, 2024

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

October 30, 2024

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

October 23, 2024

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

September 23, 2024

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

September 9, 2024

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 4, 2024

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

August 13, 2024

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

August 11, 2024

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

August 4, 2024

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

June 24, 2024

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

June 19, 2024

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

May 13, 2024

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

May 9, 2024

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

April 9, 2024

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

April 8, 2024

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

April 3, 2024

NeuroOnes’s Innovative Electrode Brain Monitoring Seeks To Provide Insights Into Neurological Disorders

March 27, 2024

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

March 25, 2024

NeuroOne® to Participate in the 36th Annual Roth Conference

March 7, 2024

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 22, 2024

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

February 12, 2024

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

February 7, 2024

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

December 13, 2023

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

December 10, 2023

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

December 6, 2023

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

November 15, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.